At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ARTL Artelo Biosciences, Inc.
Closed Mourning Day 01-08 16:00:00 EST
1.17
+0.02
+1.48%
盘后1.17
+0.000.00%
17:48 EST
High1.17
Low1.09
Vol38.30K
Open1.14
D1 Closing1.15
Amplitude6.84%
Mkt Cap3.78M
Tradable Cap3.75M
Total Shares3.23M
T/O43.61K
T/O Rate1.20%
Tradable Shares3.20M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Artelo Biosciences Is Maintained at Buy by D. Boral Capital
BRIEF-Artelo Biosciences Announces Promising New Data On Novel Non-Opioid Treatment Approach For Osteoarthritis Pain At The 13Th Annual Musculoskeletal Repair And Regeneration Symposium
Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13TH Annual Musculoskeletal Repair and Regeneration Symposium
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.